Form 4 for CL Colgate-Palmolive
Accepted 2022-02-11 00:00:00 ET · period of report 2022-02-09 · accession 0001225208-22-001888 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-11 | 2022-02-09 | CL | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | S - Sale+OE | $81.00 | -25.0K | 6,701 | -79% | -$2.02M |
| D | 2022-02-11 | 2022-02-09 | CL | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | M - OptEx | $72.99 | +25.0K | 31.7K | +373% | +$1.82M |
| D | 2022-02-11 | 2022-02-09 | CL | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | M - OptEx | $0.00 | -25.0K | 36.0K | -41% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-09 | S | D | 25,000 | $81.00 | 6,701 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-09 | M | A | 25,000 | $72.99 | 31,701 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-02-09 | M | D | 25,000 | $0.00 | 35,976 | D | $72.99 · — to 2022-09-08 | 25,000 Common Stock | (F3) Option became exercisable in one-third increments beginning on the first anniversary of the September 8, 2016 grant date. |